About Structure Therapeutics
Developing accessible oral small molecule therapies for the treatment of chronic diseases including obesity.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- South San Francisco, California
- Founded
- 2017
- Company type
- Public Company
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world.
Specialties
- Metabolic Diseases
- Cardiovascular Diseases
- Pulmonary
- Diabetes
- Computational Chemistry
- and Obesity
Company locations
601 Gateway Blvd, Suite 900, South San Francisco, California 94080, US
11F, Changtai Plaza Building A, Lane 2889 Jinke Road, Shanghai, China 201203, CN
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Care
- Biotechnology
- Product Research
- Medical
- Pharmaceutical
On LinkedIn
- Followers
- 12,936
- People linked to this company
- 202
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
1,054,400,640 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.